Back to Browse Journals

Neurobehavioral HIV Medicine

Dr Ferrando

The New York-Presbyterian Hospital, Weill Cornell Medical College, United States

Dr Ferrando

Editor-in-Chief:  Professor Ferrando

Dr. Ferrando is Professor of Clinical Psychiatry and Public Health and Vice Chair for Psychosomatic Medicine and Departmental operations at The New York-Presbyterian Hospital, Weill Cornell Medical College. He graduated from Northwestern University Medical School, did his psychiatry residency training at the University of California, San Francisco and subsequently did an NIMH-funded HIV/AIDS neuropsychiatry research training fellowship at Weill Cornell. Dr. Ferrando has focused his clinical work and research on the neuropsychiatric and quality of life aspects of HIV/AIDS and other chronic illnesses.

His research interests in HIV/AIDS include psychiatric epidemiology, treatment of depression, Hepatitis C co-infection, substance abuse, body composition changes, adherence to antiretroviral treatment and the neurocognitive aspects of HIV. He and his colleagues were among the first to document the neuropsychological benefits of combination antiretroviral therapy for HIV-associated neurocognitive impairment.

 Dr. Ferrando has authored numerous peer-reviewed articles and book chapters and serves as a peer reviewer for both medical and psychiatric journals. He is senior editor of "Psychiatry-in-Review," a psychiatry board review guide, as well as the "Clinical Manual of Psychopharmacology in the Medically Ill," published by the American Psychiatric-Press, Inc. Dr. Ferrando is past president of the New York Area Society for Liaison Psychiatry, is a Fellow of the Academy of Psychosomatic Medicine and is a member of the American Psychiatric Association Committee on AIDS.

Honorary Editorial Board

Joseph R. Berger, Professor of Neurology and Chief of the MS Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

David Clifford, Seay Professor of Clinical Neuropharmacology in Neurology, Washington University in St. Louis, Departments of Neurology and Medicine, Saint Louis, Missouri, USA

Robert Dantzer, Professor of Psychoneuroimmunology, Head of the Integrative Immunology and Behavior Program, Departments of Animal Sciences and Medical Pathology, University of Illinois at Urbana-Champaign, Illinois, USA

Ian Paul Everall, Cato Professor and Head, Department of Psychiatry, University of Melbourne, Australia

Jeffrey D. Fisher, Professor, Department of Psychology, Director, Center for Health, Intervention and Prevention, University of Connecticut, Storrs, Connecticut, USA

Magnus Gisslén, Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden

W. David Hardy, MD, Senior Director, Evidence-based Practices (Research), Whitman-Walker Health, Washington, DC; and Adjunct Professor of Medicine, Johns Hopkins University School of Medicine, USA

Michael Lewis, University Distinguished Professor, Institute for the Study of Child Development, Department of Pediatrics, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA

Lynn C. Miller, Professor, Annenberg School for Communication, Los Angeles, CA, USA

Muhammad Mukhtar, Professor of Biotechnology and Chairman, Department of Biotechnology, American University of Ras Al Khaimah (AURAK), United Arab Emirates

Kevin Robertson, Director Neuropsychology, Adult Neurology, AIDS Dementia Center, Chapel Hill, USA

Majda M. Thurnher, Professor of Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Waehringer Guertel, Vienna, Austria